Back
Novo Nordisk AS Vs. Zealand Pharma AS Industry Stock Comparison
Sell
43
NVO
Novo Nordisk AS
Last Price:
134.90
Seasonality Move:
4.32%
Buy
70
ZLDPF
Zealand Pharma AS
Last Price:
133.41
Seasonality Move:
9.95%
Sell
43
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $132.06. The Score for NVO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Zealand Pharma AS (ZLDPF)
is a Buy
Is Zealand Pharma AS a Buy, Sell or Hold?
- The current Zealand Pharma AS [ZLDPF] share price is $133.41. The Score for ZLDPF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- ZLDPF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $132.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
ZLDPF Stock Price Chart
What is Zealand Pharma AS's stock price today?
-
The Zealand Pharma AS share price today is $133.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZLDPF is experiencing slight buying pressure.
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 46.02 | Sell |
Chaikin Money Flow: | -634415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.57 - 137.25) | Sell |
Bollinger Bands (100): | (129.24 - 140.76) | Sell |
ZLDPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.28 | Buy |
Relative Strength Index (14 RSI): | 55.53 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.14 - 135.44) | Buy |
Bollinger Bands (100): | (95.97 - 134.53) | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 133.94 | Sell |
20-day SMA: | 134.74 | Sell |
50-day SMA: | 133.59 | Sell |
200-day SMA: | 125.7 | Buy |
8-day EMA: | 133.94 | Sell |
20-day EMA: | 134.12 | Sell |
50-day EMA: | 134.25 | Sell |
200-day EMA: | 124.76 | Buy |
ZLDPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.64 | Buy |
20-day SMA: | 129.35 | Buy |
50-day SMA: | 130.34 | Buy |
200-day SMA: | 95.45 | Buy |
8-day EMA: | 132.28 | Buy |
20-day EMA: | 130.56 | Buy |
50-day EMA: | 126.89 | Buy |
200-day EMA: | 99.32 | Buy |
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.92 per share.
Zealand Pharma AS Earnings Growth & ZLDPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Zealand Pharma AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |